We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Draft Guidance Lays Out Time Clock Strategies for PMAs, 510(k)s
U.S. FDA Draft Guidance Lays Out Time Clock Strategies for PMAs, 510(k)s
November 2, 2012
The U.S. Food and Drug Administration (FDA) has released updated guidance describing how it intends to comply with submission review timelines set during user fee negotiations earlier this year.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor